People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SutroVax, Inc. | — | Biotechnology | Series D+ | $205.9M | $4.5B | 2017 |
| Asher Biotherapeutics, Inc. | — | Biotechnology | Series D+ | $163.5M | $654.9M | 2024 |
| Cirius Therapeutics, Inc. | — | Biotechnology | Series B | $49.6M | $3.3M | 2019 |
Elaine Sun at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elaine Sun on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Heron | 1 | 11 |
| Patrick Enright | 1 | 10 |
| Patrick J. Heron | 1 | 7 |
| Peter Hirth | 1 | 7 |
| Kurt Von Emster | 1 | 6 |
| Ian Clark | 1 | 5 |
| Robert Zerbe | 1 | 5 |
| Robert Beardsley | 1 | 5 |
| Tracy Saxton | 1 | 5 |
| Robert A. Beardsley | 1 | 4 |
| Nilesh Kumar | 1 | 4 |
| Mark Olesnavage | 1 | 4 |
| William J. Newell | 1 | 3 |
| Daniel Estes | 1 | 3 |
| Ashish Khanna | 1 | 3 |
| Grant E Pickering | 1 | 2 |
| Craig Gibbs | 1 | 2 |
| Michael Jandernoa | 1 | 2 |
| Howard Dittrich | 1 | 2 |
| William Newell | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.